ANI Pharmaceuticals ( NASDAQ:ANIP – Get Rating ) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.09-$2.59 for the period, compared to the consensus estimate of $2.62. The company issued revenue guidance of $360.00 million-$385.00 million, compared to the consensus revenue estimate of $352.49 million. ANI Pharmaceuticals Stock Performance ANIP traded up $0.31 on Thursday, reaching $43.44. 162,165 shares of the stock were exchanged, compared to its average volume of 65,815.

https://www.dailypolitical.com/2023/03/09/ani-pharmaceuticals-nasdaqanip-updates-fy-2023-earnings-guidance.html

#dailypolitical